RHO CAPITAL PARTNERS INC

Q2 2014 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2014
Date filed
7/22/2014
Form type
13F-HR
Num holdings
6
Total value ($000)
$257,370
Net value change ($000)
+1,212 (0.5%)
New positions
0
Sold out positions
0
Turnover %
0.0%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/13/2014 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2014
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
EVERYDAY HEALTH INC 26,529 32.1%
Top Reduces (Value $000, Stocks/ETFs)
INTRALINKS -8,697 -13.1%
REACHLOCAL -7,248 -28.6%
CARA THERAPEUTICS INC -4,243 -8.5%
NEPHROGENEX INC -2,694 -25.0%
ANACOR PHARMACEUTICALS INC -2,435 -11.4%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type